Biotech Industry News

A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Bailey Lipschultz - Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge
Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge
Bloomberg

When Jan Skvarka joined biotechnology firm Trillium Therapeutics Inc. as chief executive officer, he made a big bet to reshape the company and went all-in on a cancer treatment platform. Now, he's reaping the rewards. It was the gamble of a…

siliconrepublic.com - silicon - How this biotech graduate became a business analyst at Accenture
How this biotech graduate became a business analyst at Accenture
Silicon Republic

What can someone who studied biotechnology expect from Accenture's graduate programme? Edel Browne, now an analyst at the firm, explains. Edel Browne joined the Accenture graduate programme having studied biotechnology at NUI Galway, where she also…

wwd.com - Jennifer Weil - Firmenich Launches Biotech and Naturals Pilot Plant
Firmenich Launches Biotech and Naturals Pilot Plant
WWD

PARIS ­­— Swiss fragrance and flavors suppler Firmenich has opened a biotechnology and naturals pilot plant and laboratory in Geneva. “Benefiting from the latest digital technology, the facility opens a new era for the…

eu-startups.com - Arnaud Terrisse - Blue biotech: What is it, and why do European startups have the potential to lead the sector?
Blue biotech: What is it, and why do European startups have the potential to lead the sector?
EU-Startups

The oceans cover 70% of our planet's surface with a vast expanse of sea water. Marine life has adapted to thrive in the extreme ambient conditions found in the sea. Human beings have been relying on the ocean's resources to sustain themselves.

benzinga.com - Shanthi Rexaline - Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Benzinga

September proved to be a mixed month as far as drug approvals are concerned, with Mallinckrodt PLC (NYSE:) and Aquestive Therapeutics Inc (NASDAQ:) facing rejections. PDUFA dates are binary events that invariably serve as make-or-break catalysts…

tallahasseejournal.com - Insumate® - Patented Peptide Sequence mcIRBP-19: a Boon for Diabetics Says Greenyn Biotechnology
Insumate® - Patented Peptide Sequence mcIRBP-19: a Boon for Diabetics Says Greenyn Biotechnology
Tallahassee Journal

Taiwan's biotech is gradually emerging. During the COVID-19 epidemic, we had a chance to see the advanced medical equipment and the effective preventive measures taken at the community level. The government took precautions, while private companies…

statnews.com - With a new CEO, a small biotech is out to prove Wall Street wrong
With a new CEO, a small biotech is out to prove Wall Street wrong
STAT

G1 Therapeutics, a North Carolina biotech company, is changing CEOs on the eve of an expected first FDA approval and hoping to shatter the industry truism about small companies struggling to sell products. Mark Velleca, who has led G1 since 2014…

ventureburn.com - Supplied - Biotech startup launches Covid-19 early warning and disease tracking solution -
Biotech startup launches Covid-19 early warning and disease tracking solution -
Ventureburn

The growth of the digital marketing industry indicates how much businesses value having a digital presence in today's always-on world and competitive market. As… Finnish developer Zynga is closing down one of its most popular web games…

endpts.com - John Carroll - The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn't going to stop them
The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn't going to stop them
Endpoints News

Quite often when I highlight a private, typically early-stage biotech company for these annual awards, I'm asked what I look for in a company. How do you define an Endpoints 11 company? There's a simple enough answer. First, I look for big ideas…

bloomberg.com - Sybilla Gross - Five Things You Need to Know to Start Your Day
Five Things You Need to Know to Start Your Day
Bloomberg

Goldman Sachs resumes job cuts. The Fed extends limits on dividends and share buybacks for the big banks. And the global economic recovery is turning into a real slog. Here are some of the things people in markets are talking about today. Goldman…

bloombergquint.com - Bailey Lipschultz - Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge
Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge
Bloomberg Quint

It was the gamble of a lifetime for the 53-year-old CEO, who decided to shutter the drug developer's lead program on treating tumors directly and instead focus on cancer-fighting technology for patients with different blood cancers. Investors…

nikkei.com - Staff Writer - Coronavirus latest: American Airlines starts furloughing 19,000
Coronavirus latest: American Airlines starts furloughing 19,000
日本経済新聞

Nikkei Asia is tracking the spread of the new coronavirus that originated in the central Chinese city of Wuhan. Global cases have reached 33,832,124, according to Johns Hopkins University in Baltimore. The worldwide death toll has hit 1,012,341. To…

nikkei.com - Staff Writer - Coronavirus latest: Moderna vaccine won't be ready by US election, CEO says
Coronavirus latest: Moderna vaccine won't be ready by US election, CEO says
日本経済新聞

Nikkei Asia is tracking the spread of the new coronavirus that originated in the central Chinese city of Wuhan. Global cases have reached 33,799,264, according to Johns Hopkins University in Baltimore. The worldwide death toll has hit 1,010,381. To…

businessinsider.com - Lydia Ramsey Pflanzer - Meet the 30 young leaders who are forging a new future for healthcare in the pandemic's shadow
Meet the 30 young leaders who are forging a new future for healthcare in the pandemic's shadow
Business Insider

Incredible Health Dr. Iman Abuzeid would frequently hear her friends and family members who practiced medicine complain about a nursing shortage. At the same time, she'd also hear from nurses that it took a long time to get hired. When she dug into…

seekingalpha.com - Star Investments - Repligen: A Niche Play On Biologics (NASDAQ:RGEN)
Repligen: A Niche Play On Biologics (NASDAQ:RGEN)
SeekingAlpha

Repligen (NASDAQ: RGEN) trades at a rather high valuation, but there are still very good reasons to buy the company today. Repligen supports the biologics industry, which has started a period of strong secular growth that should fuel growing cash…

Receive a Daily briefing on Biotech Industry News